---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-046031"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2021-08-27T23:59:59+00:00"
generated_at: "2026-06-29T07:20:20.055755+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CSO Jane Gross to resign Sept 14, 2021; will consult through Dec 31, 2021

## Summary
- Jane Gross resigns as Chief Scientific Officer effective Sept 14, 2021; transitions to consultant through Dec 31, 2021.
- Receives lump-sum $166,000 cash payment by Jan 7, 2022; hourly rate for transition hours beyond stated limit.
- Vested stock options exercisable for 90 days from Jan 1, 2022.
- Non-compete and non-solicitation obligations for 12 months following last day of employment.
- Company has commenced search for a new Chief Scientific Officer.

## SEC filing metadata
- accession: 0001564590-21-046031
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2021-08-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000156459021046031/0001564590-21-046031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000156459021046031/apvo-8k_20210825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-046031
- JSON: https://secwatch.observer/filing/0001564590-21-046031.json
- Plain text: https://secwatch.observer/filing/0001564590-21-046031.txt

## Key facts
- Executive change
  Jane Gross resigned as Chief Scientific Officer at Aptevo Therapeutics Inc..
  - Action: resigned
  - Role: Chief Scientific Officer
  source text: On August 25, 2021, Jane Gross (“Gross”) resigned as the Chief Scientific Officer of Aptevo Therapeutics Inc. (the “Company”) effective September 14, 2021 (“Separation Date”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671584/000156459021046031/0001564590-21-046031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.